Table 3.
Critical appraisal of studies with the highest level of evidence from each medical field
| Medical sector | Neoplasms | Oral and Maxillofacial | Oral and Maxillofacial | Oral and Maxillofacial | Oral and Maxillofacial | Oral and Maxillofacial | Oral and Maxillofacial | Oral and Maxillofacial | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | ||
| + | Yes | ||||||||||||||||||||||
| - | No | ||||||||||||||||||||||
| ? | Unable to determine | ||||||||||||||||||||||
| x | Not applicable | ||||||||||||||||||||||
| Date | 2014 | 2015 | 1999 | 2013 | 2014 | 2015 | 2010 | 2014 | 2013 | 2015 | 2012 | 2015 | 2012 | 2016 | 2013 | 2016 | 2016 | 2011 | 2016 | 2016 | 2011 | ||
| First author | de Farias | Ahrberg | D’Urso | Al-Ahmad | Ayoub | Goh | Van de Velde | Vercruyssen | Chareancholvanich | Chen | Du | Gan | Hendel | Maini | Merc | Shuang | Stephens | Wu | Yang | You | Zhang | ||
| 1. Clear hypothesis/aim/objective | Reporting | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
| 2. Clear outcome measures | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 3. Patient characteristics described | + | + | + | + | + | + | + | + | + | + | - | + | - | + | + | - | + | - | - | - | - | ||
| 4. Interventions clearly described | + | + | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | + | + | + | ||
| 5. Distributions of confounders described | + | + | + | x | - | - | - | - | - | + | + | + | - | - | + | + | - | - | - | + | + | ||
| 6. Findings clearly described | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 7. Estimates given of random variability | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 8. Adverse events reported | + | - | - | - | - | - | + | + | + | + | - | + | + | + | + | + | - | + | + | + | - | ||
| 9. Patients lost to follow-up described | x | x | x | + | x | + | + | + | + | + | + | x | - | x | x | + | + | + | x | + | + | ||
| 10. Probability values reported | + | + | - | + | - | + | + | - | + | - | + | + | + | + | + | + | + | + | + | + | + | ||
| 11. Recruitment pool represents population | External validity | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | + | ? | + | ? | ? | + | ? | + | ? | |
| 12. Participants represent population | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | ? | + | ? | + | ? | ? | + | ? | + | ? | ||
| 13. Staff/places/facilities match standard treatment | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ? | + | + | + | + | ||
| 14. Participants blinded to intervention | Internal validity - bias | + | + | - | + | - | - | - | - | - | + | - | - | - | - | - | - | + | - | - | - | - | |
| 15. Those measuring outcomes blinded | + | + | - | + | - | + | + | + | + | - | - | + | + | - | - | - | + | - | - | - | - | ||
| 16. Data dredging reported | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 17. Adjusted for different lengths of follow-up | x | x | x | + | x | + | + | + | - | + | - | x | ? | x | x | ? | + | - | x | - | - | ||
| 18. Appropriate statistical tests | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 19. Reliable compliance with intervention | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 20. Accurate/reliable outcome measures | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 21. Groups recruited from same population | Internal validity - confounding | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |
| 22. Groups recruited over same timeframe | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 23. Subjects randomised into intervention | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | ||
| 24. Randomised intervention concealed | + | + | ? | + | ? | ? | ? | ? | ? | + | ? | ? | - | ? | ? | + | + | ? | ? | ? | ? | ||
| 25. Adjustment for confounding | ? | + | - | + | - | - | - | - | - | + | - | - | - | - | - | + | - | - | - | + | + | ||
| 26. Losses to follow-up accounted for | x | x | x | + | x | + | + | + | + | + | + | x | ? | x | x | + | + | + | x | + | + | ||
| 27. Sufficient power | Power | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | + | |